ERBB2 and neoplasm: Further complicating HER2 classification is that intratumoral heterogeneity of HER2 expression (defined as at least 5% of tumor having at least a 2-degree change in HER2 expression intensity [20]) is quite common in USC, ranging between 31% and 100% of cases [21].